Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis.
[benign recurrent intrahepatic cholestasis]
Lipoprotein
metabolism
in
FIC
1
deficiency
due
to
ATP
8
B
1
mutations
has
never
been
studied
sufficiently
.
This
study
was
performed
to
investigate
the
detailed
lipoprotein
metabolism
in
benign
recurrent
intrahepatic
cholestasis
(
BRIC
)
caused
by
FIC
1
deficiency
.
Lipoprotein
profile
and
major
lipoprotein
regulators
such
as
lecithin
:
cholesterol
acyltransferase
(
LCAT
)
,
hepatic
triglyceride
lipase
(
HTGL
)
,
lipoprotein
lipase
,
and
cholesteryl
ester
transfer
protein
in
a
Japanese
patient
with
BRIC
were
serially
examined
during
a
bout
of
cholestasis
.
Liver
expression
of
farnesoid
X
receptor
(
FXR
)
,
which
suppresses
high
-density
lipoprotein
(
HDL
)
generation
,
was
also
examined
.
Hypercholesterolemia
and
lipoprotein
X
accumulation
were
never
observed
throughout
this
study
.
When
the
cholestasis
was
severe
,
triglyceride-rich
low
-density
lipoprotein
(
LDL
)
accounted
for
most
of
the
plasma
lipoproteins
whereas
HDL
was
hardly
detectable
.
Concurrently
,
activities
of
all
regulators
were
decreased
,
together
with
decreases
of
the
serum
parameter
for
liver
protein
synthesis
.
In
particular
,
suppressions
of
LCAT
and
HTGL
activities
were
severe
and
greatly
contributed
to
the
appearance
of
triglyceride-rich
LDL
.
As
the
cholestasis
improved
,
this
LDL
gradually
transformed
into
normal
LDL
with
the
recoveries
of
LCAT
and
HTGL
activities
.
The
activities
of
all
regulators
for
the
last
1
to
2
months
were
normal
but
HDL
remained
depleted
.
His
liver
showed
low
FXR
expression
compared
with
control
livers
.
The
present
study
showed
an
appearance
of
triglyceride-rich
LDL
due
to
suppressions
of
LCAT
and
HTGL
activities
and
a
depletion
of
HDL
that
is
not
able
to
be
explained
by
lipoprotein
regulators
or
FXR
in
our
patient
.
Diseases
Validation
Diseases presenting
"detailed lipoprotein metabolism in benign recurrent intrahepatic cholestasis"
symptom
benign recurrent intrahepatic cholestasis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom